What are the clinical features of NMDA (N-methyl-D-aspartate) receptor encephalitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clinical Features of NMDA Receptor Encephalitis

NMDA receptor encephalitis presents with a characteristic constellation of psychiatric symptoms, memory deficits, seizures, dyskinetic movements, decreased consciousness, and autonomic instability, predominantly affecting young women with a median age of 23 years. 1

Core Clinical Presentation

Psychiatric and Cognitive Symptoms

  • Psychiatric symptoms or memory problems occur in 100% of patients and are often the initial presenting features 1
  • Behavioral changes, personality alterations, psychosis, mania, aggression, and speech abnormalities are common psychiatric manifestations 2, 3
  • Disorientation, confusion, and cognitive dysfunction with memory deficits occur frequently 2, 4
  • These psychiatric symptoms can be mistaken for primary psychiatric illness, occasionally with tragic consequences if the diagnosis is delayed 2

Neurological Features

  • Seizures occur in 76% of patients, with intractable seizures and refractory status epilepticus being particularly characteristic 1, 4
  • Dyskinetic movements are present in 86% of patients, including choreoathetosis, orofacial dyskinesias, and other movement disorders 1, 2
  • Decreased consciousness or unresponsiveness develops in 88% of patients as the disease progresses 1, 4
  • Focal neurological signs may be present, though the presentation can be variable 2

Autonomic and Respiratory Dysfunction

  • Autonomic instability occurs in 69% of patients, representing a severe manifestation of the disease 1
  • Hypoventilation requiring mechanical ventilation develops in 66% of patients 1

Demographic and Epidemiological Features

  • The median age at presentation is 25 years with a male-to-female ratio of 1:2 5
  • The disease predominantly affects young women, with 91 of 100 patients in one major series being female 1
  • NMDA receptor encephalitis is the single most common cause of encephalitis in patients under 30 years of age, exceeding HSV, West Nile virus, and varicella zoster virus combined 6, 4

Clinical Progression Pattern

  • The presentation is typically subacute, evolving over weeks to months 2
  • Fever may be present but is not universal; some patients present with low-grade pyrexia rather than high fever 2
  • The disease follows a characteristic progression: psychiatric symptoms → seizures → movement disorders → decreased consciousness → autonomic instability 1

Associated Tumor Features

  • 58-59% of patients have associated tumors, most commonly ovarian teratoma in women 1
  • In female patients over age 18, up to 50% harbor ovarian teratomas 2, 6
  • Tumors are rare in children but become increasingly common after age 18 2

Distinguishing Clinical Clues

  • Faciobrachial dystonic seizures are a particularly distinctive feature that should raise suspicion 2
  • Hyponatremia may be present and suggests antibody-mediated encephalitis 2
  • The combination of psychiatric presentation with dyskinetic movements in a young woman is highly characteristic 2

Pediatric Considerations

  • In children, epilepsy and abnormal movements are more frequent at onset compared to adults 2
  • The overall clinical syndrome is similar but may present more acutely in pediatric populations 2

Important Clinical Pitfalls

  • Initial presentations can be subtle, with isolated psychiatric symptoms that may be misdiagnosed as primary psychiatric disorders 2, 3
  • Some patients may have a normal Glasgow Coma Score at presentation, as it is a crude tool for detecting subtle behavioral changes 2
  • The disease can develop following viral infections (HSV, VZV, EBV, influenza A), so consider testing in patients with viral encephalitis who exhibit slow response or recrudescent symptoms 4
  • Initial antibody testing can be falsely negative, requiring repeat testing if clinical suspicion remains high 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

NMDA Receptor Antibody Testing in Epilepsy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnosing Teratomas in NMDA Receptor Encephalitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of NMDA Receptor Encephalitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.